Volume 2; Issue 10

Nature Reviews Cancer

Volume 2; Issue 10
1

Ligand-targeted therapeutics in anticancer therapy

Year:
2002
Language:
english
File:
PDF, 2.52 MB
english, 2002
2

c-MYC: more than just a matter of life and death

Year:
2002
Language:
english
File:
PDF, 1.08 MB
english, 2002
3

Clinical translation of angiogenesis inhibitors

Year:
2002
Language:
english
File:
PDF, 793 KB
english, 2002
4

Transcription factors as targets for cancer therapy

Year:
2002
Language:
english
File:
PDF, 3.19 MB
english, 2002
5

Deregulated homeobox gene expression in cancer: cause or consequence?

Year:
2002
Language:
english
File:
PDF, 3.52 MB
english, 2002
6

Anti-oestrogenic prevention of breast cancer — the make or break point

Year:
2002
Language:
english
File:
PDF, 593 KB
english, 2002
7

VEGF and the quest for tumour angiogenesis factors

Year:
2002
Language:
english
File:
PDF, 196 KB
english, 2002
8

Small cause, large effect

Year:
2002
Language:
english
File:
PDF, 135 KB
english, 2002
9

Dual control

Year:
2002
Language:
english
File:
PDF, 130 KB
english, 2002
10

Not so innocent

Year:
2002
Language:
english
File:
PDF, 73 KB
english, 2002
11

Welcome interference

Year:
2002
Language:
english
File:
PDF, 71 KB
english, 2002
12

One step closer...

Year:
2002
Language:
english
File:
PDF, 60 KB
english, 2002
13

10.1038/nrc917

Year:
2002
Language:
english
File:
PDF, 83 KB
english, 2002
14

Caffeine — a new cancer cure?

Year:
2002
Language:
english
File:
PDF, 73 KB
english, 2002
15

Fuzzy logic

Year:
2002
Language:
english
File:
PDF, 181 KB
english, 2002
16

Death-defining feat

Year:
2002
Language:
english
File:
PDF, 89 KB
english, 2002
17

Self destruction

Year:
2002
Language:
english
File:
PDF, 89 KB
english, 2002
18

10.1038/nrc923

Year:
2002
Language:
english
File:
PDF, 60 KB
english, 2002
19

Mystery molecule

Year:
2002
Language:
english
File:
PDF, 77 KB
english, 2002